Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trametinib Alone and in Combination With GSK2141795 in Patients With Advanced Uveal Melanoma
NCT01979523Phase 2Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Nov 2013
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of uprosertib in Uveal melanoma (UM), sponsored by National Cancer Institute. Started Nov 2013; status: active, not recruiting.
02
Drugs
uprosertib
03
Conditions
Uveal melanoma (UM)
Beyond the preview
Go deeper on NCT01979523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01979523.